Synapse
⌘+K
Sign In
Sign Up for Free
Synapse
Sign In
Sign Up for Free
Home
Communities
Explore
More
Language
English
English
Genfit (France)
h-index: 38
Total citations: 7,528
Total papers: 85
Homepage:
https://www.genfit.com/
Recent papers from Genfit (France)
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
Nature Medicine · 2026
Serial measurements of NIS2+® enable monitoring disease evolution in patients with MASH: A retrospective cohort analysis
Hepatology Communications · 2025
Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH
JHEP Reports · 2024
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis
New England Journal of Medicine · 2023
NIS2+™, an effective blood-based test for the diagnosis of at-risk nonalcoholic steatohepatitis in adults 65 years and older
Hepatology Communications · 2023
NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study
Journal of Hepatology · 2023
Effects of subtotal pancreatectomy and long‐term glucose and lipid overload on insulin secretion and glucose homeostasis in minipigs
Endocrinology Diabetes & Metabolism · 2023
Functional Characterization of Transgenic Mice Overexpressing Human 15-Lipoxygenase-1 (ALOX15) under the Control of the aP2 Promoter
International Journal of Molecular Sciences · 2023
A randomized placebo-controlled trial of elafibranor in patients with primary biliary cholangitis and incomplete response to UDCA
Journal of Hepatology · 2021
The anti-influenza M2e antibody response is promoted by XCR1 targeting in pig skin
Scientific Reports · 2017
Fructose overfeeding in first-degree relatives of type 2 diabetic patients impacts energy metabolism and mitochondrial functions in skeletal muscle
Molecular Nutrition & Food Research · 2016
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Gastroenterology · 2016
Low WSS Induces Intimal Thickening, while Large WSS Variation and Inflammation Induce Medial Thinning, in an Animal Model of Atherosclerosis
PLoS ONE · 2015
The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db / db mice without peroxisome proliferator-activated receptor gamma–associated adverse cardiac effects
Diabetes and Vascular Disease Research · 2014
Pan-PPAR Modulation Effectively Protects APP/PS1 Mice from Amyloid Deposition and Cognitive Deficits
Molecular Neurobiology · 2014
Regulation of Energy Metabolism and Mitochondrial Function in Skeletal Muscle During Lipid Overfeeding in Healthy Men
The Journal of Clinical Endocrinology & Metabolism · 2014
The Identification of Naturally Occurring Neoruscogenin as a Bioavailable, Potent, and High-Affinity Agonist of the Nuclear Receptor RORα (NR1F1)
SLAS DISCOVERY · 2013
Dual Peroxisome Proliferator–Activated Receptor α/δ Agonist GFT505 Improves Hepatic and Peripheral Insulin Sensitivity in Abdominally Obese Subjects
Diabetes Care · 2013
Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Hepatology · 2013
PPARα is involved in the multitargeted effects of a pretreatment with atorvastatin in experimental stroke
Fundamental and Clinical Pharmacology · 2013